Inhibition of PI3K/mTOR Pathways In Glioblastoma and Implications for Combination Therapy with Erlotinib, Temozolomide, and Radiation

被引：0
|
作者：
Prasad, G. [1 ]
Sottero, T. [1 ]
Yang, X. [1 ]
Mueller, S. [1 ]
James, D. [1 ]
Berger, M. [1 ]
Aftab, D. T. [2 ]
Prados, M. D. [1 ]
Haas-Kogan, D. A. [1 ]
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Exelixis Inc, San Francisco, CA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2009年 / 75卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2009.07.172
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S67 / S68
页数：2
相关论文
共 50 条
  • [31] Combination Therapy: JAK PI3K/mTOR. A Novel Approach for Cancer Treatment
    Abdel-Magid, Ahmed F.
    ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (05): : 429 - 430
  • [32] Targeted Inhibition of the PI3K/Akt/mTOR Signaling Axis: Potential for Sarcoma Therapy
    Wani, Atif Khurshid
    Singh, Reena
    Akhtar, Nahid
    Prakash, Ajit
    Nepovimova, Eugenie
    Oleksak, Patrik
    Chrienova, Zofia
    Alomar, Suliman
    Chopra, Chirag
    Kuca, Kamil
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2024, 24 (16) : 1496 - 1520
  • [33] Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway
    Morgan, Todd M.
    Koreckij, Theodore D.
    Corey, Eva
    CURRENT CANCER DRUG TARGETS, 2009, 9 (02) : 237 - 249
  • [34] PI3K Signaling Pathways as a Molecular Target for Glioblastoma Multiforme
    da Silva, Andressa Leticia Lopes
    de Araujo, Thiago Pina Goes
    Ferreira, Shakira Cavalcante de Albuquerque
    Leite, Anderson Brandao
    da Silva, Joao Kaycke Sarmento
    Albuquerque, Lilyana Waleska Nunes
    de Lima, Ana Rachel Vasconcelos
    Barros, Herbert Charles Silva
    Silva, Leandro Rocha
    da Silva-Junior, Edeildo Ferreira
    de Araujo-Junior, Joao Xavier
    Neto, Vivaldo Moura
    de Queiroz, Aline Cavalcanti
    Alexandre-Moreira, Magna Suzana
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2024, 25 (01) : 12 - 26
  • [35] Fibroblast-induced paradoxical PI3K pathway activation in colorectal cancer: Role of PTEN and potential implications for PI3K/mTOR inhibition
    Bazzichetto, C.
    Conciatori, F.
    Ciuffreda, L.
    Falcone, I.
    Cognetti, F.
    Milella, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S185 - S185
  • [36] PI3K/AKT/mTOR
    Umemura, Shigeki
    Goto, Koichi
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S116 - S117
  • [37] In vitro effects of PI3K/mTOR inhibition in canine hemangiosarcoma
    Pyuen, Alex A.
    Thamm, Douglas H.
    CANCER RESEARCH, 2016, 76
  • [38] Inhibition of PI3K/AKT/mTOR pathway for the treatment of endometriosis
    Barra, Fabio
    Desideri, Lorenzo Ferro
    Ferrero, Simone
    BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (17) : 3626 - 3627
  • [39] Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K/Akt/mTOR-addicted lymphomas
    Bhatt, Aadra P.
    Bhende, Prasanna M.
    Sin, Sang-Hoon
    Roy, Debasmita
    Dittmer, Dirk P.
    Damania, Blossom
    BLOOD, 2010, 115 (22) : 4455 - 4463
  • [40] Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors
    LoRusso, Patricia Mucci
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (31) : 3803 - +
12345